Zogenix engages in the development and commercialization of products for the treatment of central nervous system disorders and pain.
Zogenix is tracked in the Tech.eu funding database. Based in San Diego, United States; active in Healthtech. Acquired by UCB in 2022. Data as of 21 Aug 2026.
